Supplemented and unsupplemented tissue sealants, methods of thei

Details Supplemented and unsupplemented tissue sealants, methods of thei Supplemented and unsupplemented tissue sealants, methods of thei

1995-06-07

2000-04-25

Smith, Lynette F.

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Oxidoreductases

424 941, 424 9464, 530380, 530381, 530382, 530383, 530399, 514 2, 514 54, A61K 3414, A61K 3822, A61K 3844, A61K 3849

Patent

active

060541229

ABSTRACT:
This invention provides a fibrin sealant dressing, wherein said fibrin sealant may be supplemented with at least one composition selected from, for example, one or more regulatory compounds, antibody, antimicrobial compositions, analgesics, anticoagulants, antiproliferatives, anti-inflammatory compounds, cytokines, cytotoxins, drugs, growth factors, interferons, hormones, lipids, demineralized bone or bone morphogenetic proteins, cartilage inducing factors, oligonucleotides polymers, polysaccharides, polypeptides, protease inhibitors, vasoconstrictors or vasodilators, vitamins, minerals, stabilizers and the like. Also disclosed are methods of preparing and/or using the unsupplemented or supplemented fibrin sealant dressing.

REFERENCES:
patent: Re33375 (1990-10-01), Luck et al.
patent: 2492458 (1949-12-01), Bering
patent: 2533004 (1950-12-01), Ferry et al.
patent: 3523807 (1970-08-01), Gerendas
patent: 3723244 (1973-03-01), Breillatt, Jr.
patent: 4265233 (1981-05-01), Sugitachi et al.
patent: 4298598 (1981-11-01), Schwarz et al.
patent: 4321711 (1982-03-01), Mano
patent: 4359049 (1982-11-01), Redl et al.
patent: 4362567 (1982-12-01), Schwarz et al.
patent: 4373519 (1983-02-01), Errede et al.
patent: 4377572 (1983-03-01), Schwarz et al.
patent: 4394370 (1983-07-01), Jefferies
patent: 4414976 (1983-11-01), Schwarz et al.
patent: 4427650 (1984-01-01), Stroetmann
patent: 4427651 (1984-01-01), Stroetmann
patent: 4442655 (1984-04-01), Stroetmann
patent: 4453939 (1984-06-01), Zimmerman et al.
patent: 4472840 (1984-09-01), Jefferies
patent: 4516276 (1985-05-01), Mittelmeier et al.
patent: 4617293 (1986-10-01), Wahlig et al.
patent: 4619989 (1986-10-01), Urist
patent: 4627879 (1986-12-01), Rose et al.
patent: 4631055 (1986-12-01), Redl et al.
patent: 4642120 (1987-02-01), Nevo et al.
patent: 4714457 (1987-12-01), Alterbaum
patent: 4717717 (1988-01-01), Finkenaur
patent: 4761471 (1988-08-01), Urist
patent: 4789732 (1988-12-01), Urist
patent: 4816339 (1989-03-01), Tu et al.
patent: 4820626 (1989-04-01), Williams et al.
patent: 4837379 (1989-06-01), Weinberg
patent: 4861757 (1989-08-01), Antoniades et al.
patent: 4874746 (1989-10-01), Antoniades et al.
patent: 4909251 (1990-03-01), Seelich
patent: 4928603 (1990-05-01), Rose et al.
patent: 4952403 (1990-08-01), Vallee et al.
patent: 4969880 (1990-11-01), Zamierowski
patent: 4983581 (1991-01-01), Antoniades et al.
patent: 5019559 (1991-05-01), Antoniades et al.
patent: 5023082 (1991-06-01), Friedman et al.
patent: 5030215 (1991-07-01), Morse et al.
patent: 5034375 (1991-07-01), Antoniades et al.
patent: 5035887 (1991-07-01), Antoniades et al.
patent: 5059123 (1991-10-01), Jernberg
patent: 5124155 (1992-06-01), Reich
patent: 5139527 (1992-08-01), Redl et al.
patent: 5171318 (1992-12-01), Gibson et al.
patent: 5171579 (1992-12-01), Ron et al.
patent: 5185001 (1993-02-01), Galanakis
patent: 5219328 (1993-06-01), Morse et al.
patent: 5226877 (1993-07-01), Epstein
patent: 5290552 (1994-03-01), Sierra et al.
patent: 5368858 (1994-11-01), Hunziker
patent: 5607694 (1997-03-01), Marx
Stemberger et al. Thorac. Cardiovas. Surgeon. vol. 30, pp. 209-214, 1982.
Adelmann-Grill et al., "Chemotactic Migration of Normal Dermal Fibroblasts Towards Epidermal Growth Factor and Its Modulation by Platelet-Derived Growth Factor and Transforming Growth Factor-Beta," European J. Cell. Biol. 51:322-326 (Apr., 1990).
Akrami et al., "Replacement of the Thoracic Aorta by Sealed Dacron Prostheses," Thoraxchirurgie 26:144-147 (1978).
Albrektsson et al., "Fibrin Adhesive System (FAS) Influence on Bone Healing Rate," Acta Orthop. Scand. 53:757-763 (1982).
Allen et al., "Influence of Endothelial Cell Seeding on Platelet Deposition and Patency in Small-Diameter Dacron Arterial Grafts," J. Vasc. Surg. 1:224-233 (1984).
Arbes et al., "First Clinical Experience with Heterologous Cancellous Bone Grafting Combined with the Fibrin Adhesive System (F.A.S.)," Arch. Orthop. Traumat. Surg. 98:183-188 (1981).
Baird et al., "Fibroblast Growth Factors," British Medical Bulletin 45(2) :438-452 (1989).
Berger et al., "Healing of Arterial Prostheses in Man: Its Incompleteness," Ann. Surg. 175(1):118-127 (1972).
Borst et al., "Fibrin Adhesive: An Important Hemostatic Adjunct in Cardiovascular Operations," J. Thorac. Cardiovasc. Surg. 84:548-553 (1982).
Bosch, V.P., "Autologous Cancellous Bone Grafting in Rabbbits Using a Fibrinogen Adhesive System," Wiener Klinische Wochenschrift 91(18):628-633 (1979).
Bosch, V.P., "Bone Grafting with Fibrin Glue," Wein Klin. Wochenschr. 93(Suppl. 124):3-26 (1981).
Bosch, V.P., "Experimental Investigations of the Effect of the Fibrin Adhesive on the Kiel Heterologous Bone Graft," Arch. Orthop. Traumat. Surg. 96:177-185 (1980).
Bosch et al., "The Technic of Fibrin Glue in Cancellous Bone Transplants," Arch. Orthop. Unfall-Chir. 90:63-75 (1977).
Burgess et al., "The Heparin-Binding (Fibroblast) Growth Factor Family of Proteins," Annual Rev. Biochem. 58:575-606 (1989).
Byrne et al., "Effect of Fibrin Glues on the Mechanical Properties of Healing Wounds," Br. J. Surg. 78841-843 (Jul., 1991).
Carter et al., "Clinical Experience with Crude Preparations of Growth Factors in Healing of Chronic Wounds in Human Subjects," in: Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications, pp. 303-317 (1988).
Clowes et al., "Graft Endothelialization: The Role of Angiogenic Mechanisms," J. Vascular Surgery 13(5):734-736 (May, 1991).
Clowes et al., "Mechanisms of Arterial Graft Healing," Am. J. Pathol. 123(2):220-230 (1986).
Conant et al., "Treatment of Condylomata Acuminata with Intralesional 5-Fluorouracil Therapeutic Implant (MPI 5003)," Clinical Res. 39(4):818A (Dec., 1991).
Cziperle et al., "Enhanced Endothelialization of Expanded Polytetrafluoroethylene Grafts by Heparin Binding Growth Factor-Type I (HBGF-1) Pretreatment," Presented at the Society of University Surgeons (Feb., 1992).
Davidson et al., "Mechanisms of Accelerated Wound Repair Using Epidermal Growth Factor and Basic Fibroblast Growth Factor," in: Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications, Alan R. Liss, Inc., pp. 63-75 (1988).
Deyerling et al., "A Suspension of Fibrin Glue and Antibiotic for Local Treatment of Myocotic Aneurysms in Endocarditis--An Experimental Study," Thorac. Cardiovasc. Surgeon 32:369-372 (1984).
Dresdale et al., "Hemostatic Effectiveness of Fibrin Glue Derived from Single-Donor Fresh Frozen Plasma," Annals of Thoracic Surgery 40(4):385-387 (1985).
Dresdale et al., "Preparation of Fibrin Glue from Single-Donor Fresh-Frozen Plasma," Surgery 97(6):750-755 (1985).
Durham et al., "A Method for Preparation of Fibrin Glue," J. Laryngology and Otology 101:1182-1186 (1987).
Dvorak et al., "Fibrin Containing Gels Induce Angiogenesis," Lab. Invest. 57(6):673-686 (1987).
Foxall et al., "Adult Human Endothelial Cell Coverage of Small-Caliber Dacron and Polytetrafluoroethylene Vascular Prostheses in Vitro," J. Surg. Res. 41:158-172 (1986).
Froesch et al., "Actions of Insulin-Like Growth Factors," Ann. Rev. Physiol. 47:443-467 (1985).
Gibble et al., "Fibrin Glue: The Perfect Operative Sealant," Transfusion 30(8):741-747 (Aug., 1990).
Gospodarowicz et al., "Structural Characterization and Biological Functions of Fibroblast Growth Factor," Endocrine Reviews 8(2):95-114 (1987).
Goudarzi, Y.M. "Clinical Experiences with a Fibrin-Nebacetin Bone Marrow Combination in the Treatment of Chronic Bone Infections and as Local Infection Prophylaxis in Non-Infected Bone Diseases," Akt. Traumatol. 13:205-209 (1983).
Graham et al., "Expanded Polytetrafluoroethylene Vascular Prosthesis Seeded with Enzymatically Derived and Cultured Canine Endothelial Cells," Surgery 91(5):550-559 (1982).
Greco et al., "Fibrin-Antibiotic Mixtures: An in Vitro Study Assessing the Possibility of Using a Biologic Carrier for Local Drug Delivery," J. Biomedical Materials Res. 2539-51 (Jan., 1991).
Greenhalgh et al., "PDGF and FGF Stimulate Wound Healing in the Genetically Diabetic Mouse," Am. J. Path. 136(6):1235-1246 (Jun., 1990).
Greisler et al., "Biomaterial Pretre

Affiliated with

Also associated with

Rating

Supplemented and unsupplemented tissue sealants, methods of thei does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Supplemented and unsupplemented tissue sealants, methods of thei, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Supplemented and unsupplemented tissue sealants, methods of thei will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-991262